• The Role of Polymorphism in the Future of Pharma

  • Jun 29 2021
  • Length: 19 mins
  • Podcast

The Role of Polymorphism in the Future of Pharma

Listen for free

View show details

  • Summary

  • Research into the benefits of polymorphs is proceeding at a revolutionary rate.

    What does the future hold for these exciting prospects and the companies who are investing these innovations?

    Join Simon Bates, our host for this episode and Business Development Manager at Rigaku Americas Corporation, as he engages in a lively roundtable discussion with six industry experts on the future of polymorphs and current challenges.

    What we talked about:


    - Stunning evolutionary advances in the field of pharmaceutical polymorphs.


    - Bringing in computational and big data solutions.


    - Challenges in patentability for smaller companies.


    - A bright future in polymorphism.

    Today’s amazing guests:


    - Steve Byrn, Professor and Dept. Head at Purdue University


    - Raj Suryanarayanan, Professor at University of Minnesota


    - Ann Newman, Solid-State and Pharmaceutical Consultant at Seventh Street Development Group


    - Ken Morris, University Professor, Director Lachman Institute for Pharmaceutical Analysis, Long Island University


    - Eyal Barash, Life Sciences Patent Attorney


    - Mansoor Khan, Professor and Vice Dean, Presidential Impact Fellow, Texas A&M University, Rangel College of Pharmacy

    For more insights into the pharmaceutical industry, subscribe to the show on Apple Podcasts, Spotify, or wherever podcasts are found.

    Listening on a desktop & can’t see the links? Just search for The Pharma Lab Show in your favorite podcast player.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about The Role of Polymorphism in the Future of Pharma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available